【Polaris Pharmaceuticals-KY】Adjustment of Organizational Structure and Manpower for US Subsidiaries

1. Date of event: 2026/05/25. 2. Company name: Polaris Pharmaceuticals Group. 3. Reason: The board has reviewed the organizational structure and resource allocation of its Northern California subsidiary (DRx) and Southern California subsidiary (PPI). Based on global industry changes and capital efficiency, the board approved an optimization plan. The goal is to enhance operational efficiency and reduce fixed costs without affecting core functions or product development. 4. Measures: The company will continue to promote resource allocation planning to strengthen financial health.